[Interferon beta and copolymer-1: mechanism of action and clinical effects in multiple sclerosis].
In the paper the review of clinical trials with interferon beta and copolimer-1 in the treatment of multiple sclerosis was presented. The effect of interferon beta and copolimer-1 on relapse frequency, disability and MRI activity has been described. The mechanism of action of interferon beta and copolimer-1 in MS was discussed.